- Home
- TPST vs LGCL Comparison
TPST vs LGCL Comparison
Compare TPST & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- LGCL
- Stock Information
- Founded
- TPST 2011
- LGCL 2009
- Country
- TPST United States
- LGCL China
- Employees
- TPST N/A
- LGCL N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- LGCL
- Sector
- TPST Health Care
- LGCL
- Exchange
- TPST Nasdaq
- LGCL NYSE
- Market Cap
- TPST 40.4M
- LGCL 48.3M
- IPO Year
- TPST N/A
- LGCL 2024
- Fundamental
- Price
- TPST $0.86
- LGCL $0.52
- Analyst Decision
- TPST Strong Buy
- LGCL
- Analyst Count
- TPST 3
- LGCL 0
- Target Price
- TPST $21.67
- LGCL N/A
- AVG Volume (30 Days)
- TPST 877.6K
- LGCL 2.5M
- Earning Date
- TPST 03-18-2025
- LGCL 11-22-2024
- Dividend Yield
- TPST N/A
- LGCL N/A
- EPS Growth
- TPST N/A
- LGCL 11.49
- EPS
- TPST N/A
- LGCL 0.14
- Revenue
- TPST N/A
- LGCL $173,306,912.00
- Revenue This Year
- TPST N/A
- LGCL N/A
- Revenue Next Year
- TPST N/A
- LGCL N/A
- P/E Ratio
- TPST N/A
- LGCL $3.76
- Revenue Growth
- TPST N/A
- LGCL N/A
- 52 Week Low
- TPST $0.70
- LGCL $0.47
- 52 Week High
- TPST $6.00
- LGCL $5.00
- Technical
- Relative Strength Index (RSI)
- TPST 40.89
- LGCL N/A
- Support Level
- TPST $0.85
- LGCL N/A
- Resistance Level
- TPST $0.95
- LGCL N/A
- Average True Range (ATR)
- TPST 0.05
- LGCL 0.00
- MACD
- TPST -0.00
- LGCL 0.00
- Stochastic Oscillator
- TPST 9.45
- LGCL 0.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.